The Pitfalls of CA19-9-Reference-Cited by-同舟云学术

The Pitfalls of CA19-9

Published:2012-08-01 Issue:2 Volume:138 Page:281-287
ISSN:1943-7722
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

Passerini Rita¹,Cassatella Maria C.¹,Boveri Sara²,Salvatici Michela¹,Radice Davide³,Zorzino Laura¹,Galli Claudio⁴,Sandri Maria T.¹

Affiliation:

1. Division of Laboratory Medicine, European Institute of Oncology, Milan, Italy

2. Preventive Gynecology Unit, European Institute of Oncology, Milan, Italy

3. Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy

4. Scientific Affairs, Abbott Diagnostics, Rome, Italy

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/138/2/281/24993583/ajcpath138-0281.pdf

Reference38 articles.

1. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentose II;Magnani;J Biol Chem,1982

2. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin;Magnani;Cancer Res,1983

3. Quantitative and qualitative characterization of cancer-associated serum glycoprotein antigens expressing fucosyl or sialosyl-fucosyl type 2 chain polylactosamine;Kannagi;Cancer Res,1986

4. Carbohydrate antigen sialyl Lewis a: its pathophysiological significance and induction mechanism in cancer progression;Kannagi;Chang Gung Med,2007

5. The detection of human pancreatic cancer-associated antigen in the serum of cancer patients;Chung;Cancer,1987

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancreatic Cancer;Journal of Clinical Oncology;2024-06-20

2. Case Report: Overcoming challenges in pancreatic cancer with liver metastases: a personalized therapeutic odyssey of TACE, ablation, and immunotherapy;Frontiers in Immunology;2023-10-11

3. Surgical Considerations for Neoadjuvant Therapy for Pancreatic Adenocarcinoma;Cancers;2023-08-19

4. Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges;Clinical Cancer Research;2023-08-11

5. Green synthesis of copper iodide nanoparticles: gamma irradiation for spectroscopic sensing of cancer biomarker CA 19-9;Journal of Radioanalytical and Nuclear Chemistry;2023-07-27